Effect of Ventrogluteal Intramuscular Injection Technique on Children

Not Applicable

Completed

• Conditions: IM Injection; Ventrogluteal Site; Children; Pain

• Registration Number: NCT07157592
• Lead Sponsor: Akdeniz University

Brief Summary

Intramuscular injection is one of the most frequently practiced basic nursing skills in emergency units. However, serious complications may develop when this skill is not applied with the correct technique.

The aim of the study is to investigate the effect of ventrogluteal intramuscular injection technique on pain and physiological parameters in children.

The quasi-experimental study was conducted with 90 children aged 6-12 years. The data were obtained from two groups: the control group, in which routine care was applied during intramuscular injection, and the intervention group, in which the ventrogluteal intramuscular injection technique was applied. The pain and physiological parameters of children in both groups before and after the intervention were compared.

The mean pulse rate was lower in the intervention group compared to the control group after the procedure (p\<0.05). When the mean pain scores after the procedure were analyzed, the scores in the intervention group were lower than in the control group (p\<0.05). The use of ventrogluteal intramuscular injection technique during in children was effective in reducing pain levels and decreasing pulse rate. These findings support incorporating this technique into routine nursing practice to enhance comfort and safety during intramuscular injections in children.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-15
• Primary Completion: 2023-12-15
• Study Completion: 2023-12-30
• Status Verified: 2025-08
• Study First Submitted: 2025-08-28
• Study First Submitted QC: 2025-08-28
• Last Update Submitted: 2025-08-28
• Study First Posted: 2025-09-05
• Last Update Posted: 2025-09-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Being 6-12 years old.
• Being willing to participate in the research.
• Not having a chronic disease or mental or neurological disability.
• Being able to communicate verbally.

Exclusion Criteria

• Taking any analgesic medication within 6 hours before the application to the emergency department.
• Having a life-threatening disease (e.g., sepsis, shock, respiratory or cardiogenic arrest).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Wong-Baker Scale (Pain Face Rating Scale)	Before and 5 minutes after the procedure	Faces represent increasing pain intensity from 0 to 5 from left to right. The leftmost face has a smiling expression indicating a pain-free state, whereas the face at the right end has a crying expression corresponding to the most severe pain. Below each face is a short description of the pain intensity: 0-no pain, 1-mild pain, 2-slightly more pain, 3-even more pain, 4-considerably more pain, and 5-most severe pain
SpO2 and pulse rate	Before and 5 minutes after the procedure	A calibrated pulse oximeter (Nellcor OxiMax N-65) was used to determine the oxygen saturation (SpO2) and pulse rate of the children before and after vaccine injection. The pulse oximeter shows the SpO2 and pulse rate on an LCD screen. It works with four AA batteries. The SpO2 and pulse rate were obtained by attaching the probe of the pulse oximeter to the thumb of the children.
Blood pressure	Before and 5 minutes after the procedure	A calibrated digital sphygmomanometer (Omron M3 Comfort) was used to determine the blood pressure of the children before and after IM injection. The sphygmomanometer shows systolic and diastolic blood pressure values on an LCD screen. A baby cuff was attached to the sphygmomanometer, and the systolic and diastolic blood pressure values were determined by attaching the cuff to the right arm of the children.

Trial Locations

Locations (1)

Akdeniz University; Antalya, Turkey (Türkiye)